+353-1-416-8900REST OF WORLD
1-800-526-8630U.S. (TOLL FREE)

Bristol-Myers Squibb Company (BMY) : Company Profile and SWOT Analysis

1 of 5
Synopsis
'Bristol-Myers Squibb Company (BMY) : Company Profile and SWOT Analysis' contains in depth information and data about the company and its operations. The profile contains a company overview, business description, financial ratios, SWOT analysis, competitive benchmarking, key facts, key employees, location and subsidiaries as well as information on products and services.

Summary
This SWOT analysis and company profile is a crucial resource for industry executives and anyone looking to gain a better understanding of the company's business.

'Bristol-Myers Squibb Company (BMY) : Company Profile and SWOT Analysis' report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format.

A standardized research methodology is followed to ensure high levels of data quality and these characteristics guarantee a unique report.

Scope
- Examines and identifies key information and issues about 'Bristol-Myers Squibb Company' for business intelligence requirements
- Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported
- Provides analysis on financial ratios along with a competitor benchmarking section
- The profile also contains information on business operations, company history, major products and services, key employees

Reasons To Buy
- Quickly enhance your understanding of the company
- Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry
- Recognize potential partnerships and suppliers
- Obtain yearly profitability figures

Key Highlights
Bristol-Myers Squibb Company (BMS) discovers, develops, licenses, manufactures and markets biopharmaceuticals and related healthcare products. The company principally offers products in the fields of cancer, infectious diseases, psychiatry disorders, diabetes, hepatitis B, HIV/AIDS, rheumatoid arthritis, cardiovascular and metabolic disorders and immune disorders. The company's products are sold to wholesalers, retail pharmacies, hospitals, government entities and medical professions. BMS also focuses on research and development (R&D) activities to develop medicines for the treatment of serious diseases. The company operates in various regions across Asia, Europe, North America and Latin America. The company has manufacture facilities in the US, Puerto Rico and in six other foreign countries. BMS is headquartered in New York, the US.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

Loading
LOADING...

3 of 5
Table of Contents
1 Business Analysis
1.1 Company Overview
1.2 Business Description
1.3 Major Products and Services
2 Analysis of Key Performance Indicators
2.1 Five Year Snapshot: Overview of Financial and Operational Performance Indicators
2.2 Key Financial Performance Indicators
2.2.1 Revenue and Operating Profit
2.2.2 Asset, Liabilities and Capex
2.2.3 Operational Efficiency
2.2.4 Solvency
2.2.5 Valuation
2.3 Competitive Benchmarking
2.3.1 Market Capitalization
2.3.2 Efficiency
2.3.3 Capital Expenditure
2.3.4 Valuation
2.3.5 Turnover - Inventory and Asset
2.3.6 Liquidity
3 Mergers & Acquisitions and Partnerships
3.1 M&A and Partnerships Strategy
4 Recent Developments
5 SWOT Analysis
5.1 SWOT Analysis - Overview
5.2 Strengths
5.3 Weaknesses
5.4 Opportunities
5.5 Threats
6 Company Statement
7 History
8 Key Employees
9 Key Employee Biographies
10 Locations and Subsidiaries
10.1 Head Office
10.2 Other Locations and Subsidiaries
11 Appendix
11.1 Methodology
11.2 Ratio Definitions
11.3 Disclaimer

List of Tables
Table 1: Major Products and Services
Table 2: Key Ratios - Annual
Table 3: Key Ratios - Interim
Table 4: Key Capital Market Indicators
Table 5: History
Table 6: Key Employees
Table 7: Key Employee Biographies
Table 8: Subsidiaries
Table 9: Locations

List of Figures
Figure 1: Revenue and Operating Profit
Figure 2: Financial Position
Figure 3: Operational Efficiency
Figure 4: Solvency
Figure 5: Valuation
Figure 6: Market Capitalization
Figure 7: Efficiency
Figure 8: Capital Expenditure
Figure 9: Valuation
Figure 10: Turnover - Inventory and Asset
Figure 11: Liquidity
Note: Product cover images may vary from those shown
4 of 5
Bristol-Myers Squibb Company
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll